Integra LifeSciences Holdings Current Ratio 2010-2025 | IART
Integra LifeSciences Holdings current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Integra LifeSciences Holdings Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $1.11B | $0.92B | 1.21 |
| 2024-12-31 | $1.08B | $0.92B | 1.17 |
| 2024-09-30 | $1.10B | $0.91B | 1.21 |
| 2024-06-30 | $1.11B | $0.33B | 3.39 |
| 2024-03-31 | $1.42B | $0.30B | 4.68 |
| 2023-12-31 | $1.06B | $0.31B | 3.45 |
| 2023-09-30 | $1.03B | $0.36B | 2.89 |
| 2023-06-30 | $1.05B | $0.38B | 2.79 |
| 2023-03-31 | $1.03B | $0.28B | 3.65 |
| 2022-12-31 | $1.16B | $0.32B | 3.62 |
| 2022-09-30 | $1.20B | $0.30B | 3.93 |
| 2022-06-30 | $1.14B | $0.30B | 3.85 |
| 2022-03-31 | $1.07B | $0.32B | 3.38 |
| 2021-12-31 | $1.15B | $0.34B | 3.39 |
| 2021-09-30 | $1.10B | $0.33B | 3.32 |
| 2021-06-30 | $1.03B | $0.32B | 3.24 |
| 2021-03-31 | $1.04B | $0.41B | 2.52 |
| 2020-12-31 | $1.24B | $0.40B | 3.09 |
| 2020-09-30 | $1.15B | $0.26B | 4.52 |
| 2020-06-30 | $0.97B | $0.21B | 4.55 |
| 2020-03-31 | $1.01B | $0.25B | 4.09 |
| 2019-12-31 | $0.86B | $0.33B | 2.59 |
| 2019-09-30 | $0.88B | $0.30B | 2.92 |
| 2019-06-30 | $0.87B | $0.32B | 2.76 |
| 2019-03-31 | $0.82B | $0.29B | 2.86 |
| 2018-12-31 | $0.78B | $0.26B | 2.95 |
| 2018-09-30 | $0.83B | $0.26B | 3.21 |
| 2018-06-30 | $0.82B | $0.23B | 3.52 |
| 2018-03-31 | $0.85B | $0.34B | 2.53 |
| 2017-12-31 | $0.82B | $0.35B | 2.36 |
| 2017-09-30 | $0.95B | $0.21B | 4.50 |
| 2017-06-30 | $0.62B | $0.18B | 3.46 |
| 2017-03-31 | $0.57B | $0.19B | 3.03 |
| 2016-12-31 | $0.50B | $0.12B | 4.01 |
| 2016-09-30 | $0.51B | $0.16B | 3.17 |
| 2016-06-30 | $0.49B | $0.15B | 3.30 |
| 2016-03-31 | $0.50B | $0.16B | 3.16 |
| 2015-12-31 | $0.44B | $0.14B | 3.15 |
| 2015-09-30 | $0.51B | $0.14B | 3.61 |
| 2015-06-30 | $0.61B | $0.16B | 3.91 |
| 2015-03-31 | $0.52B | $0.13B | 4.12 |
| 2014-12-31 | $0.53B | $0.13B | 4.20 |
| 2014-09-30 | $0.56B | $0.13B | 4.32 |
| 2014-06-30 | $0.56B | $0.13B | 4.45 |
| 2014-03-31 | $0.54B | $0.12B | 4.62 |
| 2013-12-31 | $0.52B | $0.12B | 4.37 |
| 2013-09-30 | $0.51B | $0.12B | 4.18 |
| 2013-06-30 | $0.48B | $0.11B | 4.37 |
| 2013-03-31 | $0.45B | $0.11B | 4.23 |
| 2012-12-31 | $0.45B | $0.11B | 4.24 |
| 2012-09-30 | $0.49B | $0.11B | 4.38 |
| 2012-06-30 | $0.48B | $0.11B | 4.25 |
| 2012-03-31 | $0.46B | $0.11B | 4.40 |
| 2011-12-31 | $0.45B | $0.10B | 4.44 |
| 2011-09-30 | $0.48B | $0.10B | 4.56 |
| 2011-06-30 | $0.50B | $0.12B | 4.20 |
| 2011-03-31 | $0.43B | $0.16B | 2.60 |
| 2010-12-31 | $0.45B | $0.20B | 2.20 |
| 2010-09-30 | $0.39B | $0.10B | 3.76 |
| 2010-06-30 | $0.39B | $0.09B | 4.53 |
| 2010-03-31 | $0.37B | $0.16B | 2.34 |
| 2009-12-31 | $0.37B | $0.16B | 2.33 |
| 2009-09-30 | $0.40B | $0.22B | 1.84 |
| 2009-06-30 | $0.42B | $0.22B | 1.95 |
| 2009-03-31 | $0.48B | $0.17B | 2.80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.986B | $1.611B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $196.080B | 85.88 |
| Thermo Fisher Scientific (TMO) | United States | $150.348B | 18.19 |
| Edwards Lifesciences (EW) | United States | $44.640B | 29.27 |
| Alcon (ALC) | Switzerland | $43.179B | 29.18 |
| IDEXX Laboratories (IDXX) | United States | $40.281B | 46.29 |
| DexCom (DXCM) | United States | $33.286B | 51.45 |
| STERIS (STE) | Ireland | $24.202B | 26.69 |
| IQVIA Holdings (IQV) | United States | $23.751B | 13.30 |
| Mettler-Toledo (MTD) | United States | $23.552B | 28.01 |
| Waters (WAT) | United States | $20.671B | 29.17 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.948B | 0.00 |
| Hologic (HOLX) | United States | $12.216B | 13.27 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Penumbra (PEN) | United States | $10.471B | 82.18 |
| Globus Medical (GMED) | United States | $8.153B | 19.12 |
| Masimo (MASI) | United States | $8.100B | 29.88 |
| Glaukos (GKOS) | United States | $5.418B | 0.00 |
| Teleflex (TFX) | United States | $5.390B | 8.90 |
| Integer Holdings (ITGR) | United States | $4.148B | 21.73 |
| TransMedics (TMDX) | United States | $4.103B | 89.20 |
| PROCEPT BioRobotics (PRCT) | United States | $3.134B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Veracyte (VCYT) | United States | $2.162B | 30.34 |
| Nihon Kohden (NHNKY) | Japan | $2.106B | 24.16 |
| Elekta AB (EKTAY) | Sweden | $2.050B | 18.43 |
| Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.442B | 0.00 |
| Artivion (AORT) | United States | $1.219B | 114.20 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| SiBone (SIBN) | United States | $0.815B | 0.00 |
| IRadimed (IRMD) | United States | $0.677B | 34.33 |
| Beta Bionics (BBNX) | United States | $0.675B | 0.00 |
| RxSight (RXST) | United States | $0.651B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.608B | 13.30 |
| Delcath Systems (DCTH) | United States | $0.600B | 0.00 |
| NeuroPace (NPCE) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.587B | 9.14 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.519B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.32 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.449B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.396B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.340B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.294B | 0.00 |
| Neuronetics (STIM) | United States | $0.264B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.87 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| 908 Devices (MASS) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.10 |
| InspireMD (NSPR) | Israel | $0.068B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.83 |
| Hyperfine (HYPR) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.042B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.03 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |